Northwest Biotherapeutics Inc (NWBO) — 10-K Filings
All 10-K filings from Northwest Biotherapeutics Inc. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Northwest Biotherapeutics Files 2024 10-K
— Mar 31, 2025 Risk: medium
Northwest Biotherapeutics Inc. reported its 2024 fiscal year results, ending December 31, 2024. The company's filing indicates significant financial activities, -
Northwest Biotherapeutics Inc. Files 2023 10-K Report
— Mar 5, 2024 Risk: high
NORTHWEST BIOTHERAPEUTICS INC (NWBO) filed a Annual Report (10-K) with the SEC on March 5, 2024. Northwest Biotherapeutics Inc. reported total assets of $106,84
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX